Flunixin Meglumine

Suppliers

Names

[ CAS No. ]:
42461-84-7

[ Name ]:
Flunixin Meglumine

[Synonym ]:
Flunixin meglumine
MFCD01725419
2-{[2-Methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1)
EINECS 255-836-0
3-pyridinecarboxylic acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-, compd. with D-glucitol, 1-deoxy-1-(methylamino)- (1:1)
FLUNIXIN N-METHYLGLUCAMINE
2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt Banamine
2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1)
Flunixin (meglumine)

Chemical & Physical Properties

[ Density]:
1.403 g/cm3

[ Boiling Point ]:
378.7ºC at 760 mmHg

[ Melting Point ]:
136-138ºC

[ Molecular Formula ]:
C21H28F3N3O7

[ Molecular Weight ]:
491.458

[ Flash Point ]:
182.8ºC

[ Exact Mass ]:
491.187927

[ PSA ]:
175.40000

[ LogP ]:
0.95620

[ Storage condition ]:
0-6°C

[ Water Solubility ]:
H2O: freely soluble | soluble

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LZ4367000
CHEMICAL NAME :
D-Glucitol, 1-deoxy-1-(methylamino)-, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3- pyridinecarboxylate (salt)
CAS REGISTRY NUMBER :
42461-84-7
LAST UPDATED :
199403
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C14-H11-F3-N2-O2.C7-H17-N-O5

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - domestic
DOSE/DURATION :
39600 ug/kg/12D-I
TOXIC EFFECTS :
Behavioral - food intake (animal) Gastrointestinal - ulceration or bleeding from stomach
REFERENCE :
JAVMA4 Journal of the American Veterinary Medical Association. (American Veterinary Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL 60196) V.48- 1915- Volume(issue)/page/year: 202,71,1993

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi:Irritant

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
LZ4367000

Articles

Pharmacokinetics and effects on thromboxane B2 production following intravenous administration of flunixin meglumine to exercised thoroughbred horses.

J. Vet. Pharmacol. Ther. 38 , 313-20, (2015)

Flunixin meglumine is commonly used in horses for the treatment of musculoskeletal injuries. The current ARCI threshold recommendation is 20 ng/mL when administered at least 24 h prior to race time. I...

Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia.

J. Neurosci. 35(1) , 96-111, (2015)

In Parkinson's disease, long-term dopamine replacement therapy is complicated by the appearance of L-DOPA-induced dyskinesia (LID). One major hypothesis is that LID results from an aberrant transcript...

Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Elife 4 , e06434, (2015)

The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-prof...


More Articles

Related Compounds

  • Flunixin Meglumine
  • iosefamate meglumine
  • Delafloxacin meglumine
  • Iothalamate meglumine
  • iosulamide meglumine
  • sulfalene meglumine
  • 2-Bromo-4-(3,3-difluoroazetidin-1-yl)benzaldehyde
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide